Last December's announcement, about the MOU with Canon...
"The commercial terms of the MOU include a US$ 1 million upfront fee and royalties of 0.5% on all device sales and 10% of the royalties received by Canon from pharmaceutical companies. Royalties in the drug delivery systems industry are typically between 5 and 15% of sales of the pharmaceutical company. The royalty stream payable by Canon to Vapotronics is expected to be very substantial."
No figure have been mentioned. Does anyone know if a payment figure or any payment has been received now that deal is done?
Thanks
Nickd
PSX Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.